News | July 16, 2025
Waters, BD biosciences unit agree to $17.5 billion merger
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
To streamline complex medical writing workflows with GenAI
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
